Search clinical trials for: DXC006

Total 37 results

Lexeo Therapeutics

Recruiting

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

Friedreich Ataxia | Cardiomyopathy, Secondary

United States, Canada
Hangzhou DAC Biotechnology Co., Ltd.

Not yet recruiting

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

Advanced Solid Tumors | Hematological Malignancies
Redx Pharma Plc
Simbec Research

Completed

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Liver Diseases | Fibrosis | Kidney Diseases | Inflammation | Idiopathic Pulmonary Fibrosis | Non-alcoholic Steatohepatitis

United Kingdom
HC Biopharma Inc.

Recruiting

A Study of HC006 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
Redx Pharma Plc
Simbec Research

Recruiting

Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

Fibrosis | IPF

Italy, Spain, United States, Belgium, United Kingdom, Austria, Czechia, Poland, Switzerland
XyloCor Therapeutics, Inc.

Completed

Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) (EXACT)

Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Angina Refractory

United States
Pierre Fabre Medical Devices

Completed

Xerotic Dermatitis in Aged People

Itching Symptoms | Xerotic Dermatitis

France
Peking University Cancer Hospital & Institute

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor

China
Peking University Cancer Hospital & Institute

Recruiting

The Molecular Imaging Research of F-18 Labeled DX600 PET Probe

Solid Tumor

China
Pacira Pharmaceuticals, Inc

Completed

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States, Canada
Dragonboat Biopharmaceutical Company Limited
West China Hospital

Recruiting

An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors

Advanced Solid Tumors (Including GCTTS)

China
HK inno.N Corporation

Completed

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301

Parenteral Nutrition

Korea, Republic of
HK inno.N Corporation

Completed

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301

Parenteral Nutrition

Korea, Republic of
Pacira Pharmaceuticals, Inc

Completed

Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

Australia
Pacira Pharmaceuticals, Inc

Completed

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Osteoarthritis, Knee

United States, United Kingdom
Pacira Pharmaceuticals, Inc

Completed

Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

Osteoarthritis, Hip

United States
Northwell Health

Recruiting

Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease

Rotator Cuff Tears | Rotator Cuff Tendinitis | Injections | Glucocorticoids | Rotator Cuff Impingement

United States
Pacira Pharmaceuticals, Inc

Completed

Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
Redx Pharma Plc

Active, not recruiting

Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies

Cancer | Solid Tumor

United Kingdom
Chong Kun Dang Pharmaceutical

Recruiting

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

Anticoagulant

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344

Anticoagulant

Korea, Republic of
University of Cambridge
Global Institute for Motorsport Safety (GIMSS) - Year 1; Neurolign Technologies... and other collaborators

Completed

Research Evaluating Sports ConcUssion Events - Rapid Assessment of Concussion and Evidence for Return (RESCUE-RACER)

Concussion, Brain | Motor Vehicle Accident

United Kingdom
Pacira Pharmaceuticals, Inc

Terminated

Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee

Post-traumatic Osteoarthritis of the Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes

Type 2 Diabetes Mellitus | Osteoarthritis of the Knee

United States
Redx Pharma Plc

Completed

A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)

Colorectal Cancer

Spain, Korea, Republic of, United Kingdom, United States
Pacira Pharmaceuticals, Inc

Completed

Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee

Osteoarthritis of the Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip

Osteoarthritis of the Hip | Osteoarthritis of the Shoulder

United States
Pacira Pharmaceuticals, Inc

Completed

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

Bilateral Knee Osteoarthritis

United States
Redx Pharma Plc
Merck Sharp & Dohme LLC

Completed

A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (KEYNOTE-E86)

Advanced Solid Tumours

United Kingdom, Australia
Pacira Pharmaceuticals, Inc

Terminated

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Osteoarthritis, Hip

United States
University of Nove de Julho
Santa Casa de Misericórdia de Porto Alegre

Completed

APT™ T3X on the COVID-19 Contamination Rate

COVID-19

Brazil
Pacira Pharmaceuticals, Inc
Medpace, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Adhesive Capsulitis | Osteoarthritis of the Shoulder

United States
The University of Texas Health Science Center,...
Pacira Pharmaceuticals

Completed

Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis

Trochanteric Bursitis

United States
University of Kansas Medical Center

Completed

The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA

Knee Osteoarthritis

United States
Pacira Pharmaceuticals, Inc

Completed

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

Hong Kong, United States, Denmark, Estonia, Lithuania, Australia, Canada, Romania
Pacira Pharmaceuticals, Inc

Completed

Study of FX006 in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States, Canada, Australia

Search clinical trials for: DXC006

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations